The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
Update: 2025-03-02
Description
In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative dendritic cell vaccine therapy designed to tackle some of the most challenging cancers, including glioblastoma and pancreatic cancer
Comments
In Channel




